Clinical Trials Browser

Interventional × Lymphedema × Bevacizumab × Clear all

NCT00393497 2014-09-22

A Pilot Study of VEGF Inhibition in Patients With Lymphedema Following Breast Cancer Treatment

Phase 1 Completed

Breast Neoplasms, Lymphedema

NCT00318513 2006-05-10

Safety Study of Bevacizumab to Treat Women With a History of Breast Cancer and Suffering From Upper Extremity Lymphedema

Phase 1 Unknown

Breast Neoplasms, Lymphedema